PATH's ARR growth decelerated for 12 consecutive quarters, with net-new ARR down 31% y/y in 4Q25, indicating poor revenue ...
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Somewhere in the loop of Reuters / CNBC newswires connected to stock traders’ terminals and the @deitaone account on X that ...